MCMedicalCodingSoftware
D3A

D3A: Benign neuroendocrine tumors

Non-billable headerICD-10-CM

D3A is a non-billable header ICD-10-CM code for benign neuroendocrine tumors. It cannot be billed on its own: choose one of the more specific child codes below.

Excludes2: not included here, but may coexist

The excluded condition is not part of this code, but a patient can have both. You may code both.

  • benign pancreatic islet cell tumors (D13.7)

Use additional code

Add a secondary code to capture the detail described below.

  • code to identify any associated endocrine syndrome, such as:
  • carcinoid syndrome (E34.00)

Code also

Both codes may be needed to describe the encounter fully. Sequencing depends on the reason for the visit.

  • any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)

Other codes that can never be billed with D3A

Their own Excludes1 notes name this code, so the conflict is not listed above.

  • D14.3Benign neoplasm of bronchus and lung
  • D15.0Benign neoplasm of thymus
  • D12.1Benign neoplasm of appendix
  • D12.8Benign neoplasm of rectum
  • D13.1Benign neoplasm of stomach
  • D13.2Benign neoplasm of duodenum
  • D13.3Benign neoplasm of other and unspecified parts of small intestine
  • D30.0Benign neoplasm of kidney

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Code history

Unchanged in every release from FY2024 to FY2027.

Code to one of these instead D3A

2 child codes. Green means billable.

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.